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Background: Bioimpedance analysis (BIA) helps measuring the constituents of the
body noninvasively. Prior studies suggest that BIA-guided ﬂuid assessment helps to
predict survival in dialysis patients. We aimed to evaluate the clinical usefulness of
BIA for predicting the survival rate of hemodialysis patients in Korea.
Methods: We conducted a single-center retrospective study. All patients were
diagnosed with end-stage renal disorder and started maintenance hemodialysis
between June 2009 and April 2014. BIA was performed within the 1st week from the
start of hemodialysis. The patients were classiﬁed into 2 groups based on volume
status measured by the body composition monitor (BCM; Fresenius): an over-
hydrated group [OG; overhydration/extracellular water (OH/ECW) >15%] and a
nonoverhydrated group (NOG; OH/ECW 15%).
Results: A total of 344 patients met the inclusion criteria. Of these, 252 patients
(73.3%) were categorized into the OG and 92 patients (26.7%) into the NOG. Age- and
sex-matching patients were selected with a rate of 2:1. Finally, 160 overhydrated
patients and 80 nonoverhydrated patients were analyzed. Initial levels of hemo-
globin and serum albumin were signiﬁcantly lower in the OG. During follow-up, 43
patients from the OG and 7 patients from the NOG died (median follow-up duration,
24.0 months). The multivariate-adjusted all-cause mortality was signiﬁcantly
increased in the OG (odds ratio, 2.569; P ¼ 0.033) and older patients (odds ratio,
1.072/y; P < 0.001). No signiﬁcant difference of all-cause or disease-speciﬁc
admission rate was observed between the 2 groups.
Conclusion: The ratio of OH/ECW volume measured with body composition
monitor is related to the overall survival of end-stage renal disorder patients who
started maintenance hemodialysis.
© 2015. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).nal Medicine, Chungnam
ro, Chung-gu, Daejeon,
hrology. Published by ElsevieIntroduction
Modern medicine has evolved in the direction of developing
less-invasive methods for a wide variety of diagnoses and
treatments. The bioimpedance analysis (BIA) method has been
used as a method to measure the constituents of the humanr. This is an open access article under the CC BY-NC-ND license (http://
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have become popular because of their convenience and safety
[1]. It is possible to measure segmental human body compo-
sition of water, muscle and fat mass, and even cardiac output
using BIA [2e4].
Assessing the precise body water status in patients with
renal disorders is very important for their health. It has been
reported that chronic ﬂuid overload is present even in the early
stages of renal insufﬁciency [5]. If the volume overload in a
patient with chronic renal failure is not controlled, serious
problems such as pulmonary edema, cardiac remodeling, and
diastolic heart failure can develop [6].
Especially for dialysis patients, an assessment of the dry
weight is essential to determine ultraﬁltration volume during
the dialysis session. It affects both hemodynamic stability and
symptoms of the patient, such as muscle cramps, abdominal
pain, generalized weakness, dyspnea, edema, hypertension, or
hypotension during and after dialysis [7,8]. Clinicians have used
predialysis and postdialysis blood pressure (BP), amount of
weight gain between dialysis sessions, and subjective symp-
toms of the patient as an index of volume overload. Recently, an
increasing number of dialysis centers have started to use body
water measurement devices using BIA.
Prior studies suggest that BIA-guided ﬂuid assessment can
help to predict survival rate in dialysis patients. Chazot et al [9]
have reported that a hyperhydrated group showed higher all-
cause mortality than a nonhyperhydrated group when they
were classiﬁed according to the ratio of overhydration/extra-
cellular water (OH/ECW) measured with multifrequency
whole-body bioimpedance spectroscopy. Fluid overload is
thought to be an independent risk factor of all-cause mortality
or cardiovascular morbidity in patients with advanced chronic
kidney disease (CKD) [10].
According to the report of the Korean Society of Nephrology,
the total number of end-stage renal disorder (ESRD) patients
was 75,042 and 52,378 patients were undergoing hemodialysis
at the end of 2013. The number of new patients undergoing
renal replacement therapy was 12,183 which included 9,543
hemodialysis patients in 2013 [11].
To date, there has been no report of survival data for Korean
patients according to the volume status measured by the BIA
method. We have used the body composition monitor (BCM;
Fresenius Medical Care, Bad Homburg, Germany) in a dialysis
center since 2009, and the hydration status measured by BCM
was correlated well with interdialysis weight gain in our pre-
vious cross-sectional study [12]. Because the BCM provides
overhydration index and suggested dry weight compared with
the reference group, it is easy to understand and apply to the
patient at the bedside [1].
The objective of this study was to evaluate the clinical use-
fulness of hydration status measured by BCM at the initiation of
hemodialysis in patients with ESRD for predicting outcomes of
dialysis patients. We analyzed the survival and admission rates
of each chronic hemodialysis patient, according to hydration
status measured by BCM.
Methods
Study design
We conducted a single-center retrospective study of dialysis
patients between June 2009 and April 2014. Most data werecollected from the electronic medical records of the Chungnam
National University Hospital. Information on mortality was
obtained from the database of the National Health Insurance
Service. We did not give physicians special treatment guide-
lines depending on hydration status; treatment of each patient
was carried out according to the clinical judgment of the
attending physician.
Patient selection
All patients were diagnosed with ESRD and started main-
tenance hemodialysis between June 2009 and April 2014.
Maintenance hemodialysis was deﬁned as hemodialysis per-
formed 1e3 times/wk for more than 3 months. BIA was per-
formed within the 1st week from the start of hemodialysis.
Exclusion criteria were as follows: a patient who started
dialysis due to acute kidney injury; a patient whose date of
dialysis start and deathwere in the same admission period; and
a patient with a history of renal transplantation, a history of
peritoneal dialysis longer than 1 month, or active malignancy
(all solid organ cancer and hematologic malignancy). Patients
were included if the cancer had completely recovered without
recurrence for more than 5 years before the start day of dialysis.
Study population
Ultimately, 344 patients met the inclusion criteria. Of these,
252 patients (73.3%) were categorized into the overhydrated
group (OG) and 92 patients (26.7%) were assigned to the non-
overhydrated group (NOG). Therewas a signiﬁcant difference of
mean age between the 2 groups in the preliminary analysis
(62.3 years in the OG and 64.4 years in the NOG). Twelve pa-
tients who were considered to be dehydrated (OH/ECW
e13%) were excluded from our analysis, and age- and sex-
matching patients were selected with the rate of 2:1; ﬁnally,
160 overhydrated patients and 80 nonoverhydrated patients
were analyzed.
Measurements of clinical parameters
Extent of overhydration and dry body weight were assessed
with the BCM. The value of initial overhydrationmeasuredwith
BCM was used without modiﬁcation, if it was measured on the
1st dialysis day. In the case that analysis with BCM was delayed
after the 1st dialysis day, the value of initial overhydration was
calculated by the difference between initial body weight and
dry body weight measured with BCM.
Based on the ratio of overhydration and extracellular water
of initial dialysis, the patients were classiﬁed into 2 groups: OG
(OH/ECW >15%) and NOG (OH/ECW 15%). The cutoff value of
our study (OH/ECW >15%) was selected with reference to the
analysis by Chazot et al [9] and Wizemann et al [13].
Baseline patient characteristics analyzed included age at
start day of dialysis (years), sex, height (cm), initial body weight
(kg), overhydration (L), dry body weight (kg), initial systolic/
diastolic BP (mmHg), initial comorbidities (presence of dia-
betes, hypertension, glomerulonephritis, cardiovascular disor-
der, or cerebral vascular disorder), and initial laboratory data
[hemoglobin, blood urea nitrogen, creatinine (Cr), albumin,
total calcium, phosphorus, sodium, potassium, chloride, C-
reactive protein, intact parathyroid hormone (PTH), iron, total
iron-binding capacity, transferrin saturation, and ferritin].
Kidney Res Clin Pract 34 (2015) 212e218214Cardiovascular disorder was deﬁned as cardiac insufﬁciency,
nonfatal myocardial infarction, angina pectoris, and atrial
ﬁbrillation. Cerebrovascular disorder was deﬁned as cerebral
infarction/embolism and intracranial hemorrhage.
Outcomes
A primary outcome was overall survival of patients. We also
compared short-term survival, long-term survival, overall rate
(days and number of events) of all-cause admissions, and dis-
ease-speciﬁc admission rate (cardiovascular disorder, cerebral
vascular disorder, infection, and malignancy) between the 2
groups.
We could have calculated the overall survival rate from the
database of the National Health Insurance Service. However,
the patients whose follow-up data were lost were excluded
from analysis of the admission rate because of the uncertainty
of this medical database. Data of the patients who received a
kidney transplant during their follow-up period were managed
as censored data.
Statistics
Mean values and frequencies of the parameters were
compared by the Student's t-test and the chi-square test. The
level of signiﬁcance was set to P < 0.05. Survival rates, ac-
cording to the baseline hydration status, were described using
the KaplaneMeier technique. The log-rank (ManteleCox) test
was used for the KaplaneMeier graph. Cox proportional hazard
models were used to compare survival according to the base-
line hydration status, adjusting for demographic data (age and
gender), comorbid conditions (diabetes, cardiovascular prob-
lems, and cerebral vascular disorders), and other predictors
(laboratory data including albumin, hematocrit, intact PTH,
predialysis phosphate, predialysis Cr). Estimated relative risks
(hazard ratios) and their 95% conﬁdence intervals were calcu-
lated with the use of the estimated regression coefﬁcients and
their standard errors. All statistical analyses were performed
using the SPSS software, version 21 (IBM Corporation, New







Dry weight (kg) 5
Systolic blood pressure (mmHg) 15
Diastolic blood pressure (mmHg) 8
Cause of ESRD
Diabetic nephropathy






Symptoms at the start of dialysis
Dyspnea related to pulmonary edema or pleural effusion
Peripheral edema
Anorexia, nausea, vomiting
Data are expressed as n (%) for categorical variables and mean ± SDs for con
ESRD, end-stage renal disorder.Results
Baseline characteristics
Average amount of overhydration was 6.6 ± 4.2 L in the OG
and 0.7 ± 1.0 L in the NOG. The OG had a lower average dry
weight even though the patients of 2 groups had comparable
initial body weight (Table 1). Initial levels of hemoglobin and
albumin were signiﬁcantly lower in the OG compared with the
NOG (Table 2). The proportion of patients presenting the
symptoms of overhydration was higher in the OG: dyspnea
related to pulmonary edema or pleural effusion (50.0% in the
OG vs. 25.0% in the NOG) and peripheral edema (36.9% in the
OG vs. 17.5% in the NOG).
There was no signiﬁcant difference in the cause of ESRD
[diabetic nephropathy (70.0% in the OG vs. 61.3% in the NOG)].
Initial comorbidities also did not exhibit signiﬁcant differences
[cardiovascular disorder (20.1% in the OG vs. 33.8% in the NOG),
cerebral vascular disorder (15.6% in the OG vs. 16.9% in the
NOG)]. No signiﬁcant difference was found in initial systolic/
diastolic BP, initial blood urea nitrogen, Cr, total calcium,
phosphorus, sodium, potassium, chloride, C-reactive protein,
intact PTH, iron, total iron-binding capacity, transferrin satu-
ration, or ferritin between the 2 groups (Table 1, 2).
Most of the enrolled patients were transferred to private
dialysis centers after stabilization of initial symptoms. Primary
symptoms or signs of overhydration were subsided within 2
weeks after the start of dialysis.
Patient survival and risk factors of death
Median follow-up duration was 24.0 months (28.5 months
for the OG vs. 19.4 months for the NOG). During the follow-up
period, 43 patients (26.9%) from the OG and 7 patients (8.8%)
from the NOG died. Patients from the OG had a higher risk for
all-cause mortality (P ¼ 0.023; Fig. 1).
The most common cause of death was infection (a total of 13
patients, including 6 patients with pneumonia, 3 patients with
sepsis, 2 patients with arteriovenous ﬁstular infection,1 patient
with deep neck infection, and 1 patient with septic arthritis).iﬁed by volume status
ted group (n ¼ 160) Nonoverhydrated group (n ¼ 80) P
98 (61.3) 49 (61.3) 1.000
5.6 ± 12.8 65.7 ± 12.6 0.957
2.8 ± 12.0 62.4 ± 11.2 0.782
6.6 ± 4.2 0.7 ± 1.0 <0.001
6.2 ± 10.7 61.7 ± 10.9 <0.001
3.8 ± 31.0 146.9 ± 31.9 0.110
0.2 ± 17.5 79.1 ± 16.9 0.653
112 (70.0) 49 (61.3) 0.782
48 (30.0) 31 (38.7) 0.164
114 (71.3) 64 (80.0) 0.130
39 (28.1) 27 (33.8) 0.140
24 (15.0) 13 (16.3) 0.850
80 (50.0) 20 (25.0) 0.001
59 (36.9) 14 (17.5) <0.000
86 (53.8) 56 (70.0) 0.013
tinuous variables, as appropriate.
Table 2. Comparison of laboratory parameters of study participants stratiﬁed by volume status
Variables Overhydrated group (n ¼ 160) Nonoverhydrated group (n ¼ 80) P
Hemoglobin (g/dL) 8.6 ± 1.8 9.3 ± 1.6 0.003
Blood urea nitrogen (mg/dL) 94.6 ± 35.9 97.0 ± 34.7 0.627
Creatinine (mg/dL) 9.3 ± 6.2 8.2 ± 3.4 0.061
Albumin (g/dL) 3.2 ± 0.6 3.5 ± 0.7 0.001
Total calcium (mg/dL) 8.6 ± 10.5 7.9 ± 1.5 0.429
Phosphorus (mg/dL) 5.8 ± 2.1 5.8 ± 1.8 0.754
Sodium (mEq/L) 135.3 ± 5.7 134.7 ± 5.0 0.444
Potassium (mEq/L) 5.0 ± 1.0 5.0 ± 0.9 0.986
Chloride (mEq/L) 104.7 ± 10.3 103.2 ± 7.8 0.200
C-reactive protein (mg/dL) 2.3 ± 4.5 2.0 ± 3.8 0.543
Intact parathyroid hormone (pg/mL) 185.8 ± 177.2 168.2 ± 141.4 0.405
Iron (mg/dL) 60.1 ± 38.5 71.7 ± 48.5 0.065
Total iron-binding capacity 208.2 ± 75.2 212.2 ± 85.5 0.722
Transferrin saturation (%) 28.3 ± 19.1 31.7 ± 21.5 0.229
Ferritin (ng/mL) 280.2 ± 244.1 315.8 ± 276.7 0.330
Data are expressed as means ± SDs for continuous variables.
Figure 1. Kaplan-Meier survival curve of two groups for all-cause
mortality.Median follow-up duration was 24.0 months. During the follow-
up period, 43 patients (26.9%) from the overhydrated group(OG) and 7
patients (8.8%) from the non-overhydrated group(NOG) died. Patients from
the OG had a higher risk for all-cause mortality (P ¼ 0.023).






Cardiovascular disorder 6 0
Cancer 5 0
Cerebrovascular disorder 2 0
Others 4 0
Unknown 16 4
Total number of patients 43 7
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tients: 3 patients with heart failure, 2 patients with cardiac
arrest, and 1 patient with aortic dissection); malignancy (5
patients: nonesmall-cell lung cancer, hepatocellular carci-
noma, advanced gastric cancer, cervical cancer, and glioblas-
toma); cerebral vascular disorder (2 patients: acute stroke and
intraventricular hemorrhage); or other disorders (4 patients: 2
patients with gastrointestinal bleeding, 1 patient with
abdominal aortic thrombosis, and 1 patient with discontinu-
ance of dialysis). We were not able to determine the cause of
death of 20 patients (Table 3).
The risk factors of death were analyzed by logistic regression
analysis and Cox regression analysis. The presence of over-
hydration [odds ratio (OR), 2.582] and older age (OR, 1.070/y)
showed a signiﬁcantly higher OR in the analysis of all 3
methods (Tables 4e6).
Overall rate of admissions
Follow-up duration of the OG (20.6 ± 15.8 months) was
longer than that of the NOG (16.2 ± 15.2 months). Follow-upduration of admission analysis was shorter than that of survival
analysis because only admission data of Chungnam National
University Hospital were available, whereas survival data were
from the database of the National Health Insurance Service.
There was no signiﬁcant difference in the all-cause admissions
rate (days and number of events) or disease-speciﬁc admission
rate (cardiovascular disorder, infection, malignancy) between
the 2 groups (Table 7).
Analysis of the patient groups reclassiﬁed according to
mortality
The patients were divided into survivors and deaths, and the
baseline characteristics were compared with each other. The
deaths showed a higher proportion of overhydrated patients
(86.0% vs. 62.1%), older age (71.6 ± 11.7 vs. 64.1 ± 12.5 years,
P < 0.001), lower body weight (59.3 ± 11.3 vs. 63.5 ± 11.7 kg,
P ¼ 0.023), and lower dry weight (53.7 ± 9.7 vs. 59.1 ± 11.2 kg,
P¼ 0.001), and also a lower serum level of albumin (3.1 ± 0.5 vs.
3.3 ± 0.7 g/dL, P¼ 0.020). There was no signiﬁcant difference in
causes of ESRD, comorbidities, all-cause admissions rate, or
disease-speciﬁc admission rate between the 2 groups.
Discussion
The overhydrated state is known to be an independent risk
factor for mortality in ESRD patients under hemodialysis
treatment [7]. Excessive volume loading can result in several
problems such as arterial hypertension, peripheral edema,
dyspnea due to pulmonary edema, left ventricular hypertrophy,
diastolic heart failure, or other adverse cardiovascular sequelae
[6e8,14]. Those previous ﬁndings are consistent with our result
Table 4. Risk factors of death during entire follow-up: univariate
logistic regression analysis
Variables Odds ratio P 95% Conﬁdence
interval
Low High
Presence of overhydration 4.768 0.001 1.841 12.351
Age 1.061 0.001 1.026 1.098
Diabetes mellitus 0.636 0.284 0.278 1.454
Hypertension 0.463 0.061 0.207 1.036
Glomerulonephritis 0.742 0.672 0.187 2.951
Cardiovascular disorder 2.134 0.049 1.002 4.545
Cerebral vascular disorder 0.667 0.416 0.252 1.768
Table 5. Risk factors of death during entire follow-up: multivariate
logistic regression analysis
Variables Odds ratio P 95% Conﬁdence
interval
Low High
Presence of overhydration 2.569 0.033 1.077 6.126
Age (/y) 1.072 <0.001 1.034 1.106
Cardiovascular disorder 2.569 0.095 0.895 3.960
Table 6. Risk factors of death during entire follow-up: Cox regression
analysis
Variables Hazard ratio P 95% Conﬁdence
interval
Low High
Presence of overhydration 2.582 0.020 1.159 5.750
Age (/y) 1.070 <0.001 1.040 1.100
Kidney Res Clin Pract 34 (2015) 212e218216that the presence of overhydration is related to higher mor-
tality of dialysis patients.
Nescolarde et al [15] used a single-frequency bioelectrical
impedance vector to volume status to investigate the associa-
tion between overhydration and mortality in dialysis patients,
and Chazot et al [9] used multifrequency bioimpedance spec-
troscopy, as used in our study. A recent study by Wizemann
et al [13] conducted using BCM also showed that overhydrationTable 7. Comparison of morbidities of study participants stratiﬁed by vo
Admission rates Overhydrated group (n ¼ 160)
Follow-up duration (mo) 20.6 ± 15.8
Overall admission
d/y 13.3 ± 29.8
Number of events/y 1.2 ± 1.6
Hospital days
d/event 8.0 ± 19.4
Disease-speciﬁc admission
Cardiovascular disorder
d/y 2.1 ± 7.3
Number of events/y 0.3 ± 0.9
Infection
d/y 6.1 ± 35.0
Number of events/y 0.3 ± 0.5
Malignancy
d/y 0.3 ± 2.2
Number of events/y 0.1 ± 0.3
Others
Number of events/y 1.5 ± 2.2
Data are expressed as mean ± SDs.
d/y, days/year.is an important and independent predictor of mortality in
chronic dialysis patients, secondary only to the presence of
diabetes.
BIA is a method that uses a change in reactance and resis-
tance of the current passing through the body ﬂuid with the
solute for measuring the body components and its distribution.
Multifrequency BIA can measure extracellular and intracellular
water separately. Low-frequency current, which cannot cross
the cell membrane, is used to measure extracellular water, and
high-frequency current, which can pass through the cell
membrane, is used to measure intracellular water [16,17]. Jang
et al [18] reported that total body water and intracellular water/
extracellular water ratio measurement with multifrequency
BIA is a useful tool to estimate adequate ultraﬁltration for
dialysis patients.
BCM uses various frequencies from 5 to 1,000 kHz to analyze
the impedance of the body. It is a reproducible, low-cost, and
noninvasive technology to measure body ﬂuid volume status of
dialysis patients, as previously reported in several studies
[19e22]. Onofriescu et al [23] demonstrated an improvement
in all-cause mortality over 2.5 years, arterial stiffness, relative
ﬂuid overload, and systolic BP after strict volume control using
BIA. We have used BCM in a dialysis center since 2009, and
hydration status measured by BCM correlated well with inter-
dialysis weight gain in our previous cross-sectional study [12].
The patients enrolled in the study by Chazot et al [9] were
under maintenance hemodialysis, whose median dialysis vin-
tagewasmore than 3 years. We analyzed patients at the start of
dialysis, so that the result could be more helpful to predict the
prognosis of dialysis patients earlier in the disease process.
There was no signiﬁcant difference between the absolute value
of overhydration between the mortality and survival groups,
but OH/ECWmeasured by the BCM was higher in the mortality
group. It emphasized the importance of the ratio of over-
hydration and extracellular water measured with the BCM, in
spite of the short follow-up duration in our study.
The most common cause of death was infection in this
study. It is similar to the results of the study by Tsai et al [10].
Tsai et al described the following as the cause: (1) lower car-
diovascular morbidity and mortality in Asians compared to
Westerners; (2) bowel wall edema due to ﬂuid overload,lume status
Nonoverhydrated group (n ¼ 80) P
16.2 ± 15.2 0.042
11.1 ± 28.2 0.584
0.9 ± 1.4 0.185
6.3 ± 14.7 0.438
1.0 ± 4.4 0.138
0.2 ± 0.5 0.126
4.3 ± 18.7 0.603
0.3 ± 0.7 0.669
0.1 ± 0.4 0.144
0.0 ± 0.1 0.124
1.1 ± 1.5 0.098
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tective barriers, and admitting overgrowth of pathogenic
species; (3) changes in brain natriuretic peptide associated
with volume status, related to diminishing the total numbers
of monocytes, B cells, and natural killer cells and impairing
natural killer cell cytotoxicity.
Cardiovascular disorders should be considered as an
important risk factor of mortality, despite our statistically
nonsigniﬁcant result. Antunes et al [24] demonstrated several
parameters reﬂecting volume overload, such as phase angle
and capacitance, help to predict cardiovascular prognosis. The
presence of cardiovascular disorder was a risk factor of mor-
tality during the entire follow-up period in our study. It is a
possible explanation that the volume overload aggravates car-
diovascular disorders as this is known to occur. The results of
our study resemble prior studies addressing the relationship of
BIA-guided ﬂuid management and improvement in cardiovas-
cular outcomes [25e27].
It is unclear whether the prognosis was improved if dialysis
started earlier before the patient became overhydrated. BIA
measurements at the 1st week from the start of hemodialysis
are unstable andmay be associated with residual renal function
or timing of the start of renal replacement therapy. Nonethe-
less, it is clear that BIA is conducive to identiﬁcation of over-
hydrated patients with advanced CKD who are not currently on
dialysis [28].
The proportion of patients presenting the symptoms of
overhydration such as dyspnea or peripheral edemawas higher
in the OG compared to NOG. Fluid overload is known to be
associated withmalnutrition and inﬂammation [29,30]. It is not
clear whether malnutrition or inﬂammation is a cause or
consequence of ﬂuid overload so far. Initial levels of hemoglo-
bin and albumin were signiﬁcantly lower in the OG, but the
level of C-reactive protein was not in this study.
Hypoalbuminemia is an important risk factor for increased
morbidity and mortality in patients on dialysis. Several
different factors contribute to hypoalbuminemia in a patient on
chronic dialysis, including malnutrition [14], chronic inﬂam-
mation [31,32], atherosclerosis [33e35], the concentration of
free toxins such as p-cresol [36], and overhydration [37]. These
prior studies are in agreement with our results.
Anemia is also associated with increased rates of hospitali-
zation andmortality in patients with CKD [38,39]. The all-cause
mortality was lowest in Korean dialysis patients with hemo-
globin levels of 10e11 g/dL [40]. The OG of our study had
signiﬁcantly lower serum levels of hemoglobin. Anemia might
have contributed to the increase of overall mortality, though
the OR was not increased to a statistically signiﬁcant degree
(data not shown). Anemia may be a secondary effect by over-
hydration rather than malnutrition or decrease in red blood
cells.
There was no signiﬁcant difference of all-cause admission
rate or disease-speciﬁc admission rate between the 2 groups.
Some following details are thought to be the cause. Most of the
enrolled patients were transferred to private dialysis centers for
maintenance dialysis on 1e2 weeks after the start of dialysis, so
admissionwith mild disorder in other hospitals may have been
missed. Some of the patients had prolonged hospitalization
periods because of complicated disorders such as infection, and
only the major cause of admission was included in the analysis.
There is also the possibility that the number of events was too
small to establish the statistical signiﬁcance.Twelve patients who were considered to be dehydrated
(OH/ECW e13%) were excluded from our analysis, and 5 pa-
tients were died during 1.83 years of follow-up. The causes of
death were as follows: 1 case of myocardial infarct, 1 case of
septic shock, 1 case of intracerebral hemorrhage, and 2 un-
known cases. Four dead patients had underlying cardiovascular
disorders (2 cases of heart failure, 1 case of prior myocardial
infarct, and 1 case of atrial ﬁbrillation). There is a possibility
that the associated cardiovascular disorders have affected the
death of the patients. It might be meaningful work to analyze
factors related to dehydration, cardiovascular disorders, and
aggravation of CKD or other serious general medical conditions
in a larger patient group.
There are several limitations to this study. First, the retro-
spective study design allows for ﬁndings to be subjective to
many other variables not analyzed in this study. Second, the
patients in the study were enrolled in a single center. Third, this
study did not include follow-up measurements of dry weight.
Serial follow-up of volume status is more important than single
measurement to guide dialysis patients toward normohydra-
tion and better BP control [20]. Further evaluation with BCM
analysis, such as multicenter prospective trials with periodic
measurement or meta-analysis of existing studies, might be
helpful.
In conclusion, the volume status measured by BCM is related
to overall survival of ESRD patients who started maintenance
dialysis. Volume status should be assessed for each patient who
is starting dialysis as an easy-to-use predictor of mortality in
the clinical environment.Conﬂicts of interest
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